Description

If you’re curious about doing business in the UK, please join BioUtah, in partnership with the UK’s Department for Business & Trade, for the first in a series of webinars to help Utah life sciences companies understand how to access the UK healthcare market. Utah’s James McCullough, co-founder and CEO of Renalytix, will speak to his own company’s experience across the pond.
 
Last year, Gov. Spencer Cox signed a Memorandum of Understanding (MOU) with the UK which includes deepening economic development and trade cooperation in the life sciences and other industry sectors. This webinar helps to advance the mission of the MOU.
 
Participant will learn about:

• The UK National Health System (NHS), NHS priorities, and the private healthcare market
• Regulations, including post BREXIT impacts
• Routes to market, health technology assessments, reimbursement and procurement
• The healthcare innovation support ecosystem including funding
• How the UK Government can support investment opportunities

• Dr Linda Magee OBE, Health Innovation and NHS Sector Specialist, Department for Business & Trade
• James McCullough,  Co-founder & CEO, Renalytix

Join Webinar »